Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet regimen for managing HIV infection. This formula integrates three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the virus's ability to multiply within the body, remarkably reducing the viral load.